This page will track the quarterly sales of Merck's checkpoint inhibitor Keytruda vs Bristol-Myers Squibb's Opdivo over time.
Who Am I?
I'm an individual investor from Kansas City. My focus is on biotech stocks, but I enjoy investing in all industries. I'm an old-school, buy and hold investor who believes the best way to outperform and grow capital is to own innovative companies with good management teams over the long-term. more>>>